How Alpha Health Finder Reviews Men's Health Providers

Our review criteria.

Every provider we list gets a 0–5 star AHF Editorial Rating, with our ceiling at 4.7 and our floor at 3.5. Providers that don't clear 3.5 don't get listed. We don't issue 4.8/4.9/5.0 ratings — every credible operation has trade-offs, and editorial ratings that don't acknowledge them read as paid.

The directory lists providers across two distinct lanes — prescription-clinical telehealth (TRT/HRT, ED, hair loss, weight loss, hormone optimization clinics) and research-compound retailers (peptide and SARM suppliers operating under research-use-only framing). The ceiling/floor and the structural review process are identical across both lanes. The specific criteria are not — they cannot be, because the operations are structurally different. We score each lane against six criteria appropriate to its model.

Prescription-clinical lane — six criteria:

1. 01
   Prescriber credentials and oversight.Are the prescribers named, licensed, and verifiable? Is there real medical oversight, or is the operation a script-mill behind a thin clinical facade?
2. 02
   Lab work and follow-up cadence.Does the provider require appropriate bloodwork before prescribing controlled medications? Are follow-up labs scheduled into the care plan?
3. 03
   Prescription pathway transparency.Where do medications come from? FDA-registered pharmacies? Named compounding pharmacies? Or vague sourcing?
4. 04
   State coverage and pricing transparency.Does the provider serve the states they claim? Is pricing published or buried behind login walls? Are add-on fees disclosed upfront?
5. 05
   Treatment evidence framing.Does the provider distinguish FDA-approved treatments from off-label uses from investigational therapies? Or are all treatments marketed as equivalently legitimate?
6. 06
   Customer experience signals.What do verified review patterns show? What complaint categories recur? What do regulators, BBB, and LegitScript say?

Research-compound lane — six criteria:

1. 01
   COA publication and per-batch traceability.Does the vendor publish Certificates of Analysis for the compounds they sell? Are COAs traceable to specific lot numbers, or are they generic marketing assets?
2. 02
   Third-party analytical testing.Are HPLC, mass-spec, or equivalent purity tests performed by an independent lab (not the vendor)? Are the labs named and verifiable?
3. 03
   Sourcing and manufacturing transparency.Where are the compounds synthesized? Is the chain of custody from synthesis to shipment documented? Or is sourcing opaque?
4. 04
   Research-use-only framing discipline.Does the vendor market for research use only, as the legal framework requires? Or do they cross the line into dosing protocols, human-consumption claims, or therapeutic positioning?
5. 05
   Operating history and reliability signals.How long has the vendor been in market? Are there established support channels? Do shipping reliability, refund handling, and order-discrepancy reports indicate a stable operation?
6. 06
   Pricing transparency and customer experience signals.Is per-vial / per-mg pricing published? Are payment processors disclosed? What do independent review patterns and community-forum signals show across the trailing 12 months?

The research-compound lane is not a substitute for clinical care, and we do not present it as one. We list it because a meaningful share of the men's-health audience is sourcing peptides directly for self-directed research, and the difference between a vendor that publishes per-lot COAs and one that doesn't is the difference between a defensible purchase and a coin-flip. Our role is to surface that difference. Treatment decisions still belong with a licensed physician.

Every provider's page has an Honest Breakdown section showing what works and what to watch for. The rating defends itself against those listed strengths and watch points. If the rating doesn't match the breakdown, we got it wrong — tell us through the /contact form.

How AHF earns money.

Alpha Health Finder is an affiliate directory. When you click through to a provider from our site and complete a purchase, the provider may pay us a commission. This is how we earn the revenue that keeps AHF free for users.

In accordance with the Federal Trade Commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising (16 CFR Part 255), we disclose:

• AHF receives affiliate compensation from many of the providers listed in this directory.
• This compensation does not influence our editorial ratings. Providers do not pay for higher ratings, and we do not adjust ratings based on commission rates. Our editorial process is structurally separate from our affiliate-revenue process.
• We do not list every provider we are offered. Providers must clear our 3.5 rating floor to appear. Several providers offering compensation have been declined or delisted.
• We do not accept money for specific phrasing, talking points, or content rewrites from any provider.

If you have questions about our affiliate relationships or want to verify our editorial independence, contact us through the /contact form.

When pages get re-reviewed.

Every affiliate provider page on this directory is re-reviewed on a minimum 6-month cadence. We update sooner when:

• A provider changes ownership, pricing, or state availability
• A regulatory action (FDA, FTC, state board) affects the provider
• A material change happens to the provider's prescribing or service model
• A pattern of new user reports surfaces that doesn't match the existing rating

Each provider page shows the last-reviewed date at the top of the AHF Editorial Rating block. If the date is more than 6 months old at the time you read it, the page is overdue for refresh — feel free to flag through the /contact form.

What we won't do.

To keep this directory honest:

• We don't take editorial direction from providers
• We don't accept ghostwritten provider content
• We don't run 'sponsored' reviews — every review on this directory is editorial
• We don't downrank providers because their commission rate is lower
• We don't uprank providers because their commission rate is higher
• We don't write provider content as if it were patient testimony

If any of those lines move, we will say so on this page.